<?xml version="1.0" encoding="UTF-8"?>
<ref id="B6-viruses-11-00826">
 <label>6.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lackenby</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Besselaar</surname>
    <given-names>T.G.</given-names>
   </name>
   <name>
    <surname>Daniels</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Fry</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Gregory</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Gubareva</surname>
    <given-names>L.V.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Hurt</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Leang</surname>
    <given-names>S.-K.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>R.T.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016â€“2017</article-title>
  <source>Antivir. Res.</source>
  <year>2018</year>
  <volume>157</volume>
  <fpage>38</fpage>
  <lpage>46</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.07.001</pub-id>
  <pub-id pub-id-type="pmid">29981793</pub-id>
 </element-citation>
</ref>
